DEARHealth Revenue and Competitors

DEARhealth is a health tech company founded in 2011, by senior University of California, Los Angeles (UCLA) medical experts to transform healthcare by using AI-powered care pathways for chronic disease management. DEARhealth is a validated, AI-driven service that has been successfully implemented in large health systems, in disease areas such as inflammatory bowel diseases, epilepsy, and ovarian cancer. Our value based health care solutions for medical providers and health insurers, which significantly improve the health outcomes and experience of chronically ill patients while dramatically reducing costs. DEARhealth features include: -A Recommender function that incorporates multiple risk-associated features to generate daily recommendations for providers, aimed at improving individual patient outcomes. -Pre-built care pathways for a wide range of disease areas, allowing highly coordinated care across multiple settings and fully customizable to fit the needs of local ecosystems. -Integration with Electronic Medical Records (EMR) systems, giving providers easy access to goal-oriented recommendations. -A companion app for patients and caregivers with various support modules, including medication adherence, disease education, COVID-19 functionality, and direct messaging. DEARhealth's partners include health systems, providers, payers, and pharmaceutical companies globally. Investors in DEARhealth include Philips Health Technology Ventures, Vesalius Biocapital III, and Health Innovations. To learn more about DEARhealth visit www.dearhealth.com or contact info [at] dearhealth.com.